The Vietnam diagnostic labs market is undergoing a significant transformation driven by a convergence of healthcare infrastructure development, technology integration, and increasing awareness of preventive health. With a valuation of USD 1320.21 million in 2024, the market is set to witness robust expansion, projected to grow at a CAGR of 6.50% from 2025 to 2034, reaching USD 2478.22 million by 2034. This momentum is fueled largely by the rising burden of chronic diseases, increased demand for timely and accurate diagnostic services, and the integration of automation and artificial intelligence in laboratory testing.
Vietnam Diagnostic Labs Market Share
In Vietnam, the diagnostic labs sector is segmented primarily into hospital-based diagnostic labs and stand-alone diagnostic labs, with hospital-based labs accounting for a considerable portion of the market share due to their advanced infrastructure and immediate access to in-patient samples. However, stand-alone labs are rapidly gaining traction, especially in urban centers, offering specialized services and convenience for outpatient care.
Among diagnostic tests, pathology testing—which includes blood, urine, and tissue analysis—maintains a significant share owing to its routine and preventive applications. On the other hand, radiology tests, including CT scans, MRIs, and ultrasounds, are rapidly growing due to their critical role in chronic disease diagnosis, cancer detection, and trauma care.
When evaluated by end-user type, walk-in patients represent a dominant group, reflecting growing public health consciousness and proactive testing behavior. Corporate clients are an emerging segment, propelled by workplace wellness initiatives, while referrals from physicians and specialists continue to be a strong traditional source of lab testing volumes.
Vietnam Diagnostic Labs Market Growth and Trends
The growth trajectory of Vietnam’s diagnostic lab sector is supported by multiple structural and consumer-level trends:
Rise in Chronic and Lifestyle-Related Diseases
Urbanization and changing lifestyles have contributed to the increasing prevalence of non-communicable diseases like diabetes, cardiovascular conditions, and cancers. This has led to a surge in demand for diagnostic screenings and long-term disease monitoring.
Public and Private Sector Investments
Vietnam’s government is focusing heavily on improving healthcare delivery by enhancing diagnostic infrastructure, especially in tier-2 and tier-3 cities. Additionally, private investments and foreign collaborations are further accelerating modernization and capacity expansion in the sector.
Digital Transformation in Diagnostics
The adoption of automated analyzers, laboratory information management systems (LIMS), and AI-based diagnostic tools is reshaping how tests are conducted and interpreted. These advancements significantly reduce errors, enhance operational efficiency, and improve turnaround times—making diagnostics more reliable and patient-centric.
Increased Health Awareness
There’s a noticeable shift in consumer behavior towards early detection and preventive healthcare, especially post-COVID-19. This trend is promoting regular health check-ups and increasing the uptake of comprehensive diagnostic packages.
Discover What’s Driving the Vietnam Diagnostic Labs Market Forward!
Get exclusive insights, growth metrics, and trend forecasts—download your free report now!
Vietnam Diagnostic Labs: Case Studies and Developments
The sector has seen numerous noteworthy developments in recent years. Diag, one of the prominent diagnostic chains in Vietnam, has expanded its network and introduced more advanced imaging and blood testing equipment. Similarly, CarePlus Clinics Vietnam has been offering specialized preventive health screening packages tailored to urban consumers.
InnoQuest, a leading diagnostic services provider in Asia, has entered into strategic collaborations in Vietnam to expand its test menu and offer high-end molecular diagnostics. Meanwhile, Vietnam Lab Testing Center has upgraded its capabilities to include next-generation sequencing (NGS), particularly in oncology and genetic testing.
Furthermore, innovations such as mobile sample collection units and telemedicine-linked diagnostics are helping labs penetrate rural and semi-urban areas, providing wider access to quality healthcare services.
Competitive Landscape and Market Analysis
The diagnostic labs market in Vietnam is moderately fragmented but increasingly competitive, with both domestic and international players vying for technological superiority and wider reach. Local players such as Himedic, Chemedic Test Center, and Plus Diagnostics are focusing on affordability, while larger networks like Medlab Vietnam and PATHLAB emphasize scale and service diversity.
Regulatory compliance plays a pivotal role in ensuring quality and standardization. Vietnam’s Ministry of Health has been working to establish stringent protocols for laboratory accreditation, equipment certification, and quality assurance. This ensures uniform service delivery, especially as medical tourism and cross-border healthcare services grow in Southeast Asia.
Regional Dynamics and Diagnostic Evolution
Vietnam’s diagnostic labs market is experiencing uneven development across its regions. The southern region, especially Ho Chi Minh City, leads the market due to the concentration of private healthcare providers, technological adoption, and higher per capita health expenditure. The northern region, including Hanoi, is also evolving rapidly with government-led hospital upgrades and private lab chains expanding their footprint.
Central provinces, while still developing, are seeing an uptick in diagnostic service access due to mobile labs, health outreach programs, and public-private partnerships. These regional dynamics will continue to shape the pace and nature of diagnostic service availability across the country.
Market Segmentation Insights
By Provider Type
-
Hospital-Based Diagnostic Labs: Benefit from in-hospital patient flow, advanced diagnostic machinery, and integrated healthcare services.
-
Stand-Alone Diagnostic Labs: Gaining market share with specialized services, speed, and convenience in urban locations.
By Test Type
-
Radiology: Includes X-rays, CT scans, MRIs, and ultrasounds; expanding due to imaging innovations.
-
Pathology: Encompasses blood, urine, and biopsy testing; remains a cornerstone of routine and preventive healthcare.
By End User
-
Walk-ins: Largest segment due to increasing consumer-driven healthcare.
-
Referrals: Traditional but steadily growing through digital integrations.
-
Corporate Clients: Expanding segment due to workplace health check-ups.
-
Others: Includes insurance-based testing and government-supported screenings.
The Role of Expert Analysis
According to Expert Market Research, the long-term sustainability of the Vietnam diagnostic labs market will depend on how efficiently providers balance cost, quality, and accessibility. As diagnostic demand continues to diversify—spanning chronic care, infectious disease monitoring, and precision medicine—the sector is poised for increased specialization, consolidation, and patient-focused innovation. The integration of point-of-care testing, big data analytics, and personalized diagnostics is expected to dominate the market’s future evolution.
For stakeholders, the key lies in understanding regional variations, investing in technological upgradation, and aligning services with patient expectations. From urban centers to remote provinces, the next decade presents vast opportunities for diagnostics to become the core of Vietnam’s modern healthcare ecosystem.
Check Out More Reports
United States Medical Spa Market
South Korea Smart Healthcare Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
